Analyst Research: Pfizer Inc (PFE)
PFE on New York Consolidated
29.54USD
19 Jun 2013
29.54USD
19 Jun 2013
Price Change (% chg)
$0.14 (+0.48%)
$0.14 (+0.48%)
Prev Close
$29.40
$29.40
Open
$29.37
$29.37
Day's High
$29.59
$29.59
Day's Low
$29.23
$29.23
Volume
42,588,706
42,588,706
Avg. Vol
46,957,568
46,957,568
52-wk High
$31.15
$31.15
52-wk Low
$22.00
$22.00
| Name | Age | Since | Current Position |
|---|---|---|---|
Ian Read |
59 | 2011 | Chairman of the Board, Chief Executive Officer |
Frank D'Amelio |
55 | 2010 | Chief Financial Officer, Executive Vice President - Business Operations |
Mikael Dolsten |
54 | 2010 | President - Worldwide Research and Development |
Douglas Lankler |
47 | 2011 | Executive Vice President, Chief Compliance and Risk Officer |
Amy Schulman |
52 | 2012 | Executive Vice President, General Counsel, Business Unit Lead - Consumer Healthcare |
- Teva, Sun Pharma to pay $2.15 billion to settle Pfizer patent suit
- UPDATE 2-Teva, Sun Pharma to pay $2.15 bln to settle Pfizer patent suit
- RPT-FEATURE-Pfizer takes its shot at a vaccine for evasive superbug
- Pfizer takes its shot at a vaccine for evasive superbug
- Pfizer to spin off Zoetis stake to shareholders

